Examples of using Relvar in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
The most common side effects with Relvar Ellipta(which may affect more than 1 in 10 people)
The safety and efficacy of Relvar Ellipta in children under 12 years of age has not yet been established in the indication for asthma.
severe liver disease, your doctor will limit your dose to the lower strength of Relvar Ellipta 92/22 micrograms once daily.
There is no relevant use of Relvar Ellipta in the paediatric population for the indication of COPD.
Relvar Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed Relvar Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed.
Relvar Ellipta should only be considered for pregnant women if the expected benefits outweigh the risks.
Allergic reactions to Relvar Ellipta are rare they affect less than 1 person in 1000.
For the treatment of asthma, Relvar Ellipta was investigated in three main studies involving a total of over 3,200 patients.
If you accidentally take more Relvar Ellipta than your doctor has instructed,
In two of the studies, Relvar Ellipta was compared with fluticasone furoate or fluticasone propionate inhalation powder alone
Rinsing your mouth out with water immediately after using Relvar Ellipta may help stop this side effect developing.
The company that makes Relvar Ellipta has agreed that its scientific data can be used for Revinty Ellipta‘informed consent.
Two different strengths of Relvar Ellipta are available:
Two studies compared different doses of Relvar Ellipta with fluticasone furoate
If your breathing or wheezing gets worse straight after using Relvar Ellipta, stop using it and get medical help immediately.
Patients usually experience an improvement in lung function within 15 minutes of inhaling Relvar Ellipta.
A starting dose of Relvar Ellipta 92/22 micrograms should be considered for adults and adolescents 12 years and over who require a low to mid dose of inhaled corticosteroid in combination with a long-acting beta2- agonist.
The European Medicines Agency has deferred the obligation to submit the results of studies with Relvar Ellipta in one
Relvar Ellipta 184/22 micrograms should be considered for adults and adolescents 12 years and over who require a higher dose of inhaled corticosteroid in combination with a long-acting beta2-agonist.
Relvar Ellipta is also used to relieve the symptoms of chronic obstructive pulmonary disease(COPD)